Alemtuzumab Induction and Prednisone‐Free Maintenance Immunotherapy in Kidney Transplantation: Comparison with Basiliximab Induction—Long‐Term Results

This study examined alemtuzumab (anti‐CD 52, Campath‐1H) and basiliximab (anti‐CD 25, Simulect) as induction immunosuppression in kidney transplantation.

[1]  D. Axelrod,et al.  Reduction of CMV Disease with Steroid‐Free Immunosuppresssion in Simultaneous Pancreas–Kidney Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  K. Budde,et al.  Proposal for Guidelines for Publication of Randomized Trials in the American Journal of Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  H. Gritsch,et al.  A Multicenter Pilot Study of Early (4‐Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and Sirolimus , 2005, American Journal of Transplantation.

[4]  J. Melancon,et al.  Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. , 2004, Transplantation.

[5]  Y. Becker,et al.  Campath-1H in renal transplantation: The University of Wisconsin experience. , 2004, Surgery.

[6]  D. Dunn,et al.  Long-term Immunosuppression, Without Maintenance Prednisone, After Kidney Transplantation , 2004, Annals of surgery.

[7]  J. Gaynor,et al.  The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results , 2004, Transplantation.

[8]  B. Kiberd,et al.  Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  G. Borm,et al.  Steroid‐Withdrawal at 3 Days After Renal Transplantation with Anti‐IL‐2 Receptor α Therapy: A Prospective, Randomized, Multicenter Study , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  J. O'grady.  Steroid‐free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  D. Harlan,et al.  RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52‐SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH‐1H) , 2003, Transplantation.

[12]  R. Colvin,et al.  Campath‐1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  A. Cohen,et al.  Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1 , 2003, Transplantation.

[14]  A. Monaco,et al.  Multicenter Randomized Prospective Trial of Steroid Withdrawal in Renal Transplant Recipients Receiving Basiliximab, Cyclosporine Microemulsion and Mycophenolate Mofetil , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  B. Kiberd,et al.  A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. , 2001, Transplantation.

[16]  S. Birkeland.  STEROID-FREE IMMUNOSUPPRESSION IN RENAL TRANSPLANTATION: A LONG-TERM FOLLOW-UP OF 100 CONSECUTIVE PATIENTS , 2001, Transplantation.

[17]  P. Friend,et al.  Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients , 1998, The Lancet.

[18]  A. Atz,et al.  Inhaled nitric oxide and heparin for infantile primary pulmonary hypertension , 1998, The Lancet.

[19]  S. Birkeland.  Steroid-free immunosuppression in renal transplantation , 1996, The Lancet.

[20]  G. Hale,et al.  Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen. , 1993, Molecular immunology.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[22]  N. Sobol,et al.  Preliminary results , 2020, Asymptotic Analysis of Random Walks: Light-Tailed Distributions.